![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- ACOG. 2012. Noninvasive prenatal testing for fetal aneuploidy. Committee Opinion No. 545. American College of Obstetricians and Gynecologists. Obstetrics and Gynecology 120:1532–1534.
- Benn P, Borell A, Chiu R, Cuckle H, Dugoff L, Faas B et al. 2013. Position Statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenatal Diagnosis 33:622–629.
- Engels MA, Heijboer AC, Blankenstein MA, van Vugt JM. 2011. Performance of first-trimester combined test for Down syndrome in different maternal age groups: reason for adjustments in screening policy? Prenatal Diagnosis 31:1241–1245.
- Gebb J, Dar P. 2009. Should the first-trimester aneuploidy screen be maternal age adjusted? Screening by absolute risk versus risk adjusted to maternal age. Prenatal Diagnosis 29:245–247.
- Gregg AR, Gross SJ, Best RG, Monaghan KG, Bajaj K, Skotko BG et al. 2013. ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genetics in Medicine 15:395–398.
- Haddow JE, Palomaki GE, Knight GJ, Cunningham GC, Lustig LS, Boyd PA. 1994. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening. New England Journal of Medicine 330:1114–1118.
- Hörmansdörfer C, Golatta M, Scharf A, Hillemanns P, Schmidt P. 2011. Age-independent first trimester screening for Down syndrome: analysis of three modified software programs with 6,508 pregnancies. Archives of Gynecology and Obstetrics 283:749–754.
- Langlois S, Brock JA. 2013. Current status in non-invasive prenatal detection of Down syndrome, trisomy 18, and trisomy 13 using cell-free DNA in maternal plasma. Journal of Obstetrics and Gynaecology Canada 35:177–181.
- Liao C, Huang Y, Li D, Song S, Yi C, Zhou J. 2006. Second-trimester maternal serum screening for Down syndrome in Mainland China. Prenatal Diagnosis 26:1271–1272.
- Muller F, Thalabard JC, Ngo S, Dommergues M. 2002. Detection and false-positive rates of maternal serum markers for Down syndrome screening according to maternal age in women over 35 years of age. A study of the agreement of eight dedicated software packages. Prenatal Diagnosis 22:350–353.
- Norton ME, Brar H, Weiss J, Karimi A, Laurent LC, Caughey AB et al. 2012. Non-invasive chromosomal evaluation (NICE) study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. American Journal of Obstetrics and Gynecology 207: 137.e1–e8.
- Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M et al. 2011. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genetics in Medicine 13:913–920.
- Schmidt P, Hörmansdörfer C, Pruggmayer M, Schütte C, Neumann A, Gerritzen A et al. 2008. Improved prenatal aneuploidy screening using the novel advanced first-trimester screening algorithm: a multicenter study of 10,017 pregnancies. Journal of Clinical Ultrasound 36:397–402.
- Spencer K. 2001. Age related detection and false positive rates when screening for Down's syndrome in the first trimester using fetal nuchal translucency and maternal serum free β hCG and PAPP-A. British Journal of Obstetrics and Gynaecology 108:1043–1046.
- Szabo J, Gellen J. 1990. Nuchal fluid accumulation in trisomy-21 detected by vaginosonography in first trimester. Lancet 336:1133.
- Wilson KL, Czerwinski JL, Hoskovec JM, Noblin SJ, Sullivan CM, Harbison A et al. 2013. NSGC practice guideline: prenatal screening and diagnostic testing options for chromosome aneuploidy. Journal of Genetic Counseling 22:4–15.